3Sherman SL.Premature ovarian failure in the fragile X syndrome.Am J Med Genet,2000, 97(3):189-194.
4Murray A. Premature ovarian failure and the FMRI gene.Semin Reprod Med,2000, 18{1):59-66.
5Scldessinger D,Herrera L,Crisponin Let al.C, enes and translocations involved in POF.Am J Med Genet,2002,111(3):328-333.
6Testa G,Chiaffarino F,Vegetti W,et al.Casecontrol study on risk factors for premature ovarian failure.Gynecol Obstet Invest,2001,51(1):40-43.
7Ishizuka B,Kudo Y,Amemiya A, et al. Anti-nucluear antibodies in pationts with premature ovarian failure.Hum Reprocl,1999,14(1 ):70-75.
8Chemyshov VP,Radysh TV,Gura IV,et al.Immune disorders in women with premature ovarian failure in initial period.Am J Reprod Immunol,2001,46(3):220-225.
9Alberto F,Stefano L, Paola C,et al.Stereid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril, 2002,78(2):270-279.
10Hoyer PB,Devine PJ,Hu X, et al.Ovarian toxicity of 4-vinylcyclohexene diepoxide:a menchanistic model.Toxicol Pathol,2001,29(l):91-99.
